{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:21:28Z","timestamp":1778678488475,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R37CA226081"],"award-info":[{"award-number":["1R37CA226081"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA209414"],"award-info":[{"award-number":["U01CA209414"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.lungcan.2021.03.007","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:33:53Z","timestamp":1615509233000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Metabolomic profiling for second primary lung cancer: A pilot case-control study"],"prefix":"10.1016","volume":"155","author":[{"given":"Jacqueline V.","family":"Aredo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4936-5540","authenticated-orcid":false,"given":"Natasha","family":"Purington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2040-9773","authenticated-orcid":false,"given":"Sophia J.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Diao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6453-199X","authenticated-orcid":false,"given":"David C.","family":"Christiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-980X","authenticated-orcid":false,"given":"Heather A.","family":"Wakelee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2013-6883","authenticated-orcid":false,"given":"Summer S.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lungcan.2021.03.007_bib0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.lungcan.2021.03.007_bib0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7326\/M13-2771","article-title":"Screening for lung cancer: U.S. Preventive services task force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.lungcan.2021.03.007_bib0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.lungcan.2021.03.007_bib0020","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.athoracsur.2017.06.065","article-title":"Patterns of treatment and outcomes for definitive therapy of early stage non-small cell lung Cancer","volume":"104","author":"Kapadia","year":"2017","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2021.03.007_bib0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/COC.0000000000000265","article-title":"Changes in treatment patterns and overall survival in patients with early-stage non-small cell lung Cancer in the United States after the incorporation of stereotactic ablative radiation therapy: a population-based analysis","volume":"41","author":"Haque","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2021.03.007_bib0030","article-title":"Cancer treatment and survivorship statistics, 2019","author":"Miller","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.lungcan.2021.03.007_bib0035","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/JTO.0b013e3182582a79","article-title":"Stage I lung cancer survivorship: risk of second malignancies and need for individualized care plan","volume":"7","author":"Surapaneni","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"18","key":"10.1016\/j.lungcan.2021.03.007_bib0040","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/jnci\/90.18.1335","article-title":"Second lung cancers in patients after treatment for an initial lung cancer","volume":"90","author":"Johnson","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.lungcan.2021.03.007_bib0045","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.1992.10.10.1519","article-title":"The incidence of second primary tumors in long-term survivors of small-cell lung cancer","volume":"10","author":"Heyne","year":"1992","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2021.03.007_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/S0003-4975(03)00821-X","article-title":"The risk of second primary tumors after resection of stage I nonsmall cell lung cancer","volume":"76","author":"Rice","year":"2003","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2021.03.007_bib0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jtcvs.2012.09.030","article-title":"Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance","volume":"145","author":"Lou","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"25","key":"10.1016\/j.lungcan.2021.03.007_bib0060","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1200\/JCO.2017.72.4203","article-title":"Risk stratification for second primary lung Cancer","volume":"35","author":"Han","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.lungcan.2021.03.007_bib0065","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.2174\/1568026617666170707120034","article-title":"Metabolomics applications in precision medicine: an oncological perspective","volume":"17","author":"Puchades-Carrasco","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"issue":"9","key":"10.1016\/j.lungcan.2021.03.007_bib0070","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/bjc.2016.305","article-title":"Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial","volume":"115","author":"Huang","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2021.03.007_bib0075","first-page":"588","article-title":"A metabolomics analysis of body mass index and postmenopausal breast Cancer risk","volume":"110","author":"Moore","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.lungcan.2021.03.007_bib0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jtho.2015.09.002","article-title":"Metabolite profiles of the serum of patients with non-small cell carcinoma","volume":"11","author":"Mazzone","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"33","key":"10.1016\/j.lungcan.2021.03.007_bib0085","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1200\/JCO.2015.61.7779","article-title":"Diacetylspermine is a novel prediagnostic serum biomarker for non-small-Cell lung Cancer and has additive performance with pro-surfactant protein B","volume":"33","author":"Wikoff","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2021.03.007_bib0090","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/0008-5472.CAN-14-0109","article-title":"Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer","volume":"74","author":"Mathe","year":"2014","journal-title":"Cancer Res."},{"issue":"70","key":"10.1016\/j.lungcan.2021.03.007_bib0095","doi-asserted-by":"crossref","first-page":"115774","DOI":"10.18632\/oncotarget.22404","article-title":"Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.lungcan.2021.03.007_bib0100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jtho.2016.01.011","article-title":"Detection of lung Cancer through metabolic changes measured in blood plasma","volume":"11","author":"Louis","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2021.03.007_bib0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2007.11.013","article-title":"Second hand smoke, age of exposure and lung cancer risk","volume":"61","author":"Asomaning","year":"2008","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2021.03.007_bib0110","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-5223(19)40289-4","article-title":"Multiple primary lung cancers","volume":"70","author":"Martini","year":"1975","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2021.03.007_bib0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The Eighth Edition Lung Cancer Stage Classification","volume":"151","author":"Detterbeck","year":"2017","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.lungcan.2021.03.007_bib0120","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/ac901536h","article-title":"Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems","volume":"81","author":"Evans","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.lungcan.2021.03.007_bib0125","first-page":"11","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B (Methodological)"},{"issue":"41","key":"10.1016\/j.lungcan.2021.03.007_bib0130","doi-asserted-by":"crossref","first-page":"70366","DOI":"10.18632\/oncotarget.19705","article-title":"A prospective study of serum metabolites and glioma risk","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2021.03.007_bib0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"issue":"W1","key":"10.1016\/j.lungcan.2021.03.007_bib0140","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"10.1016\/j.lungcan.2021.03.007_bib0145","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/bioinformatics\/btq418","article-title":"MetPA: a web-based metabolomics tool for pathway analysis and visualization","volume":"26","author":"Xia","year":"2010","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.lungcan.2021.03.007_bib0150","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7150\/jca.27160","article-title":"5\u2019-Methylthioadenosine and Cancer: old molecules, new understanding","volume":"10","author":"Li","year":"2019","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2021.03.007_bib0155","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Team","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2021.03.007_bib0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2019.09.001","article-title":"Let us not underestimate the long-term risk of SPLC after surgical resection of NSCLC","volume":"137","author":"Leroy","year":"2019","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.lungcan.2021.03.007_bib0165","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/mc.22694","article-title":"Metabolomic signature of brain cancer","volume":"56","author":"Pandey","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"5","key":"10.1016\/j.lungcan.2021.03.007_bib0170","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9050102","article-title":"Breast Cancer metabolomics: from analytical platforms to multivariate data analysis. A review","volume":"9","author":"Silva","year":"2019","journal-title":"Metabolites"},{"issue":"9","key":"10.1016\/j.lungcan.2021.03.007_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024143","article-title":"Plasma free amino acid profiling of five types of cancer patients and its application for early detection","volume":"6","author":"Miyagi","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lungcan.2021.03.007_bib0180","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1158\/1541-7786.MCR-12-0437-T","article-title":"Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor","volume":"11","author":"Chaudhri","year":"2013","journal-title":"Mol. Cancer Res."},{"issue":"9","key":"10.1016\/j.lungcan.2021.03.007_bib0185","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1039\/C3MB70138G","article-title":"Exploratory investigation of plasma metabolomics in human lung adenocarcinoma","volume":"9","author":"Wen","year":"2013","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.lungcan.2021.03.007_bib0190","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1186\/1471-2407-10-690","article-title":"Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study","volume":"10","author":"Maeda","year":"2010","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.lungcan.2021.03.007_bib0195","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.biocel.2003.11.016","article-title":"Methylthioadenosine","volume":"36","author":"Avila","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.lungcan.2021.03.007_bib0200","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/1940-6207.CAPR-14-0329","article-title":"Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma","volume":"8","author":"Wikoff","year":"2015","journal-title":"Cancer Prev. Res. Phila. (Phila)"},{"issue":"2","key":"10.1016\/j.lungcan.2021.03.007_bib0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jcb.21984","article-title":"Direct and tumor microenvironment mediated influences of 5\u2019-deoxy-5\u2019-(methylthio)adenosine on tumor progression of malignant melanoma","volume":"106","author":"Stevens","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"19","key":"10.1016\/j.lungcan.2021.03.007_bib0210","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1016\/j.chroma.2010.01.025","article-title":"Quantification of intermediates of the methionine and polyamine metabolism by liquid chromatography-tandem mass spectrometry in cultured tumor cells and liver biopsies","volume":"1217","author":"Stevens","year":"2010","journal-title":"J. Chromatogr. A"},{"issue":"4","key":"10.1016\/j.lungcan.2021.03.007_bib0215","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1166\/jbn.2019.2719","article-title":"Detection of lung Cancer by analysis of exhaled gas utilizing extractive electrospray ionization-mass spectroscopy","volume":"15","author":"Zuo","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"issue":"5","key":"10.1016\/j.lungcan.2021.03.007_bib0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11306-017-1199-6","article-title":"Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics","volume":"13","author":"Lindahl","year":"2017","journal-title":"Metabolomics"},{"key":"10.1016\/j.lungcan.2021.03.007_bib0225","doi-asserted-by":"crossref","unstructured":"J. Huang, A.M. Mondul, S.J. Weinstein, A. Derkach, S.C. Moore, J.N. Sampson, D. Albanes, Prospective serum metabolomic profiling of fatal prostate cancer [abstract]. Proceedings of the American Association for Cancer Research Annual Meeting 2018, Cancer Res 78(13 Suppl) (2018) Abstract nr 3224.","DOI":"10.1158\/1538-7445.AM2018-3224"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500221001033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500221001033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:31:01Z","timestamp":1778675461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500221001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":45,"alternative-id":["S0169500221001033"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2021.03.007","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic profiling for second primary lung cancer: A pilot case-control study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2021.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}